In 2016 NICE is due to commence the review of this guidance, to register as a stakeholder please contact us at

NICE has developed medical technology guidance on the EXOGEN ultrasound bone healing system.

NICE medical technologies guidance addresses specific technologies notified to NICE by manufacturers. The 'case for adoption' recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This 'case' is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

NICE has said that EXOGEN can be used to treat non-union fractures of long bones (such as the tibia or femur, long bones in the leg). Non-union means that the fracture hasn't healed after 9 months. Healthcare teams may want to use the EXOGEN ultrasound bone healing system because the evidence shows high rates of fracture healing when it is used and it can save money, by avoiding surgery, compared with current treatment for non-union fractures.

  • National Institute for Health and Care Excellence (NICE) accreditation logo